Noradrenaline
Hypotensive Disorder
The Second Affiliated Hospital of Dalian Medical UniversitySmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
1 Active assets in the Hypotensive Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
M-Sympathol The Second Affiliated Hospital of Dalian Medical University | Phase 4 | BB |
Ephedrine, Anhydrous University Hospital, Clermont-Ferrand | Phase 4 | BB |
L-Bupivacaine University Hospital Dubrava | Phase 4 | BB |
Imisopasem Manganese MetaPhore Pharmaceuticals | Phase 1/2 | CCC |
Marcaine Ankara University | Unknown | D |
Midodrine The Cleveland Clinic | N/A | D |
Fentanyl Ankara University | Unknown | D |
Nitroglycerin Tablets Liang Bing | N/A | NR |
Same molecule, other indications
Noradrenaline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →